News & Analysis on Clinical Trial Services & Contract Research And Development
Vetter: clinical manufacturing site
By Jenni Spinner
- Last updated on
One year after purchasing a clinical manufacturing site in Rankweil, Austria, Vetter has announced the facility has been upgraded to be in line with the company’s aseptic fill and finish standards for drug-delivery systems. It features 100,000 square feet of offices, laboratory space, areas for material preparation, storage (room-temperature, cool, and frozen), and an automated vial filling line for liquid and lyophilized products.
“With this additional facility we will further expand our capability for early clinical development for phase I and phase II drug candidates,” said managing director Peter Soelkner. “The dedicated manufacturing site will focus on supporting our customers on quality, timeliness and technical expertise.”